Cargando…
Erratum: Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats
Autores principales: | Ezrokhi, Michael, Luo, Shuqin, Trubitsyna, Yelena, Cincotta, Anthony H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535856/ https://www.ncbi.nlm.nih.gov/pubmed/26273326 http://dx.doi.org/10.1186/s13098-015-0056-x |
Ejemplares similares
-
Neuroendocrine and metabolic components of dopamine agonist amelioration of metabolic syndrome in SHR rats
por: Ezrokhi, Michael, et al.
Publicado: (2014) -
Time-of-Day-Dependent Effects of Bromocriptine to Ameliorate Vascular Pathology and Metabolic Syndrome in SHR Rats Held on High Fat Diet
por: Ezrokhi, Michael, et al.
Publicado: (2021) -
Experimental dopaminergic neuron lesion at the area of the biological clock pacemaker, suprachiasmatic nuclei (SCN) induces metabolic syndrome in rats
por: Luo, Shuqin, et al.
Publicado: (2021) -
Erratum to: Gender differences in metabolic syndrome components among the Korean 66-year-old population with metabolic syndrome
por: Lee, Sangjin, et al.
Publicado: (2016) -
Erratum to “Gastroenteropancreatic Neuroendocrine Neoplasia Characterization in Portugal: Results from the NETs Study Group of the Portuguese Society of Endocrinology, Diabetes and Metabolism”
por: Santos, A. P., et al.
Publicado: (2020)